Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Prostatic Neoplasms 32Brain Neoplasms 21Carcinoma, Non-Small-Cell Lung 19Neoplasm Metastasis 17Lung Neoplasms 15Carcinoma, Hepatocellular 13Breast Neoplasms 10Pancreatic Neoplasms 9Melanoma 9Carcinoma, Renal Cell 9Neoplasms 7Colorectal Neoplasms 7Spinal Cord Neoplasms 3Small Cell Lung Carcinoma 3Prostate Cancer Metastatic 3Nasopharyngeal Carcinoma 3Kidney Neoplasms 3Adenocarcinoma 3Urinary Bladder Neoplasms 2Unresectable Locally Recurrent Rectal Cancer 2Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Radiation Injuries 2Osteosarcoma 2Oligometastatic Prostate Cancer 2Neuroma, Acoustic 2Neoplasms by Site 2Klatskin Tumor 2Head and Neck Neoplasms 2

Interventions

sacubitril and valsartan sodium hydrate drug combination 1dostarlimab 1Tyrosine Kinase Inhibitors 1Surveys and Questionnaires 1Semen Analysis 1Registries 1Radiosurgery 1Probiotics 1Patient Reported Outcome Measures 1Interviews as Topic 1Folfox protocol 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Neoplasms, Second Primary × Radiosurgery × Clear all
NCT05733156 2024-12-10

KROG22-11

Soonchunhyang University Hospital

Phase NA Recruiting
52 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms, Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡